Background: Pancreatic cancer is a highly lethal malignancy. We therefore aimed to compare RNA concentration, purity, integrity, and laboratory-assigned pre-assay quality control (QC) classifications between paired fresh-frozen (FF) and formalin-fixed, paraffin-embedded (FFPE) endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) specimens from solid pancreatic lesions. Methods: We evaluated 36 pairs of FF and FFPE EUS-FNB specimens for RNA concentration, absorbance ratios, RNA quality numbers (RQNs), and pre-assay QC classifications. FF tissues were placed in RNAlater-containing tubes, snap-frozen and transported in liquid nitrogen before storage in an ultra-low-temperature freezer at −80 °C at the biobank, whereas FFPE specimens were processed and stored according to routine institutional protocols. QC classifications were assigned by the analytical laboratory based on RNA measurements, electropherograms, and estimated assay input requirements. Results: FF specimens had significantly higher RNA concentrations, A260/A280 and A260/A230 ratios, and RQNs than paired FFPE specimens (all p < 0.001). No specimens achieved “Pass” status. All 36 FF specimens were classified as “Hold,” whereas 25 of 36 FFPE specimens (69.4%) were classified as “Fail” (p < 0.001). Archival storage duration was significantly longer in the FFPE “Fail” group than in the “Hold” group (median, 5.52 versus 4.14 months; p = 0.006). Conclusions: The FF workflow yielded significantly superior RNA quality metrics and fewer pre-assay QC failures than the FFPE workflow. Placement of specimens in tubes prefilled with RNAlater, followed by snap-freezing and storage at −80 °C, may offer a practical strategy for banking small pancreatic EUS-FNB specimens. However, as pre-assay QC does not guarantee downstream assay success, further validation of profiling performance and long-term stability is warranted.
Background: Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic condition driven by complex interactions among genetic, microbial, immunological, and environmental factors that substantially affect patients’ lives and increase the risk of colorectal cancer (CRC). Biobanks support IBD research by providing access to human biospecimens and associated data. This study aimed to describe the workflow and infrastructure of the Kyungpook National University Hospital (KNUH) Biobank, summarize the clinical characteristics of participants and the collection and distribution of biospecimens, and outline future development priorities. Methods: This descriptive report summarizes the collection and distribution activities of the KNUH Biobank from 1 July 2021 to 31 December 2025, including biospecimens collected at Kyungpook National University Chilgok Hospital and incorporated into its collection. Biospecimens and associated clinical and epidemiological data were collected from consenting participants, processed, and stored according to standard operating procedures. Bioresource distribution required formal application and committee approval. Results: The disease-focused collection comprised 1307 participants: 471 with CD (36.0%), 376 with UC (28.8%), 35 with other non-infective gastroenteritis and colitis (2.7%), and 425 with CRC (32.5%). Of these, the mean age at diagnosis was 37.7 years (SD, 23.1), and 849 participants (65.0%) were male. A total of 9577 biospecimen vials were collected from these 1307 participants, excluding the bottom-up collection. Additionally, excluding the bottom-up collection, 2400 vials were distributed through 34 approved applications during the reporting period. Conclusions: This report describes the operational framework and collection and distribution activities of the KNUH Biobank. Future priorities include improving clinical data completeness, establishing systematic longitudinal follow-up, and evaluating resource utilization and operational sustainability.